Hims & Hers Health shares are in the spotlight Monday ahead of its second-quarter earnings report due today after the market closes.
Hims & Hers Health Inc.
(NYSE:HIMS) shares are in the spotlight Monday ahead of the company's second-quarter earnings report today after the market closes.
Hims & Hers Health shares are under pressure.
Why is HIMS stock retreating?
Earnings Preview & History Hims & Hers is expected to report a loss of 1 cent per share along with revenue of $699.89 million.
Hims & Hers posted Q2 results - here are the details you need to know.
HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding…
Hims & Hers stock falls after Q2 earnings miss estimates despite beating revenue targets. Here is what drove the stock down.
Telehealth platform Hims & Hers Health (HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to…
Hims & Hers Health is trading lower Friday as stock digests CMO appointment and gives back repair-rally gains, with breadth…
In June, Hims & Hers shares tumbled more than 30% after a short-lived collaboration with Novo Nordisk fell apart.
